Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-beta1 in patients with grade 3 chronic degenerative joint disease of the knee - Cherian, J J; Parvizi, J; Bramlet, D (Osteoarthritis Cartilage, 2015)